HCPCS Level II · Drugs administered other than oral method
J2820Injection, sargramostim (gm-csf), 50 mcg
✓ Active
Source: CMS HCPCS quarterly update, October 2026. Page updated September 29, 2026.
About J2820
J2820 is an HCPCS Level II code in the J series (drugs administered other than oral method), describing injection, sargramostim (gm-csf), 50 mcg.
It was added to HCPCS effective 01/01/1982, and its current record took effect 01/01/1998.
Its Medicare coverage code is "D", meaning special Medicare coverage instructions apply.
Details
- Short description
- Sargramostim injection
- Date added
- 01/01/1982
- Action effective
- 01/01/1998
- BETOS
- O1E
Related J28xx codes
- J2800Injection, methocarbamol, up to 10 ml
- J2801Injection, risperidone (rykindo), 0.5 mg
- J2802Injection, romiplostim, 1 microgram
- J2804Injection, rifampin, 1 mg
- J2805Injection, sincalide, 5 micrograms
- J2810Injection, theophylline, per 40 mg
- J2840Injection, sebelipase alfa, 1 mg
- J2850Injection, secretin, synthetic, human, 1 microgram
- J2860Injection, siltuximab, 10 mg
- J2865Injection, sulfamethoxazole 5 mg and trimethoprim 1 mg
Common questions about J2820
Is HCPCS J2820 still valid?
- Yes. J2820 is active in the CMS October 2026 HCPCS file.
Does Medicare cover J2820?
- Its coverage code is "D": special Medicare coverage instructions apply. Check the local coverage determination for your region.